Abstract
Objective
To report the clinical outcome of a patient who received high-dose intravitreal triamcinolone acetonide as treatment for severe macular oedema secondary to adult Coat's syndrome.
Method
Case report.
Results
A 74-year-old Indian man complaining of chronic gradual blurring of vision in the left eye was found to have adult Coat's syndrome with severe macular oedema. He received 25 mg of intravitreal triamcinolone acetonide following unsuccessful resolution with grid laser. Optical coherence tomography (OCT) demonstrated up to 75% decrease in macular oedema that was evident even after 9 months follow-up. However, there was no significant improvement in visual acuity.
Conclusion
Intravitreal triamcinolone is a reasonable option in reducing severe macular oedema in cases of adult Coat's syndrome.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular oedema: preliminary results of a prospective controlled trial. Ophthalmology 2004; 111: 218–224.
Jonas J, Kreissig I . Intravitreal triamcinolone acetonide as treatment of macular oedema in central retinal vein occlusion. Graefe's Arch Clin Exp Ophthalmol 2002; 240: 782–783.
Degenring R, Jonas J . Intravitreal injection of triamcinolone acetonide as treatment for chronic uveitis. Br J Ophthalmol 2003; 87: 361.
Jonas J, Kreissig I, Degenring R . Intravitreal triamcinolone acetonide for pseudophakic cystoid macular oedema. Am J Ophthalmol 2003; 136: 384–386.
Jonas JB, Akkoyun I, Budde WM, Kreissig I, Degenring RF . Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration. Arch Ophthalmol 2004; 122: 218–222.
Jonas J . Intravitreal triamcinolone acetonide as treatment for extensive exudative retinal detachment. Br J Ophthalmol 2004; 88: 587–588.
Khairallah M, Yahia SB, Ladjimi A, Attia S, Megdiche Z, Zaouali S et al. Intravitreal triamcinolone acetonide for diabetic macular oedema with severe hard exudates. Program and abstracts of the American Academy of Ophthalmology 2003 Annual Meeting; Nov 15–18, 2003; Anaheim, CA PO117 (unpublished).
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors declare that they have no financial or proprietary interest in the products mentioned or described in this paper.
Rights and permissions
About this article
Cite this article
Jarin, R., Teoh, S. & Lim, T. Resolution of severe macular oedema in adult Coat's syndrome with high-dose intravitreal triamcinolone acetonide. Eye 20, 163–165 (2006). https://doi.org/10.1038/sj.eye.6701828
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.eye.6701828
Keywords
This article is cited by
-
Use of intravitreal triamcinolone and bevacizumab in Coats' disease with central macular edema
Graefe's Archive for Clinical and Experimental Ophthalmology (2011)
-
Role of intravitreal bevacizumab in adult onset Coats’ disease
International Ophthalmology (2011)
